IDO1 and glioblastoma: Kesarwani et al. found that kynurenine was accumulated in human glioblastoma tumors and the radiation-induced regulatory T cells in a mouse model of glioblastoma could be mitigated by the treatment of an IDO1 inhibitor, GDC-0919 [32].